EMEA-001676-PIP01-14-M05
Key facts
| Invented name |
Pifeltro
|
| Active substance |
doravirine
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0505/2022
|
| PIP number |
EMEA-001676-PIP01-14-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of human immunodeficiency virus type 1 (HIV-1) infection
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|